Mandate

Vinge advises Eleda in connection with acquisition of One Nordic

May 09, 2020 M&A

Vinge has advised Eleda Infra Services Group (“Eleda”) on the acquisition of One Nordic from Altor Fund III.

ONE Nordic is one of Sweden's leading suppliers of technical services in electricity transmission infrastructure and renewable energy production. With a nationwide organization and local knowledge, ONE Nordic delivers high quality services and solutions to energy producers, distributors and energy users with around 1,000 employees and sales of approximately SEK 2.1 billion in 2019. One Nordic broadens Eleda’s capabilities into electricity transmission infrastructure services and projects focusing on electricity distribution and renewable energy (wind and hydro power). The acquisition is carried out in connection with Altor Fund V’s acquisition of a majority stake in Eleda and Eleda’s acquisition of Järfälla VA- & Byggentreprenad AB.

Vinge’s team consisted of partner Christina Kokko together with associates Michaela Cronemyr, Fredric Reissmüller, Manne Bergström and Hanna Risberg (M&A) and the due diligence team of partner Johan Cederblad with associates Lova Unge, Elias Lundin, Lisa Ullman, Sofia Landolsi, Tove Lövgren Frisk, Anna Li, Olof Löfvenberg, Arvid Axelryd, Lisa Hörnqvist, Jonathan Riddersholm and VDR assistant Nathalie Hughes.

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025